Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), often combined with systemic therapy, can be offered to selected colorectal peritoneal metastases (PM) patients. However, clinical heterogeneity and the lack of high-level evidence challenges determination of the corr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Manag Res
Autori principali: Simkens, Geert A, Wintjens, Anne G W E, Rovers, Koen P, Nienhuijs, Simon W, de Hingh, Ignace H
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257566/
https://ncbi.nlm.nih.gov/pubmed/34234566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S277912
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi